Top Digital Therapeutics startups to watch
We’ve ranked the top digital therapeutics startups to watch based on Dealroom Signal: a powerful algorithm helping VCs, Corporates and Governments find the most promising up-and-coming startups.
Digital therapeutics, or DTx, are playing an increasingly central role in the future of healthcare, by delivering an evidence-based intervention via software or medical device to prevent, manage, treat or complement a disease treatment.
Digital therapeutics focuses on a range of medical conditions and supports various stages of the traditional healthcare process. These products go from tracking and managing symptoms, to delivering cognitive behavioural therapy and treatments for musculoskeletal and gastrointestinal conditions.
Digital therapeutics is still a young health sector, but fastest-growing in recent years. It received a record $2.7B in funding in 2021, and year-to-date funding has already surpassed 2020 funding levels at $1.1B. There are currently 8 digital therapeutics unicorns globally.
Don’t think of this list as a ranking of the “best startups” in digital therapeutics, but instead as the top startups to watch based on their fundraising timeline, growth indicators, founding team, and a number of other factors.
As we gather more data, we’ll update this list later in the future to reflect changes happening in these companies and were they stand.
For investors, this is a highly relevant list specifically for those looking for ripe startups to invest in. For startups, the completeness of your company profile also contributes to your position in the rank.
Don’t miss the latest up-and-coming digital therapeutics startups, access the full list here. 👈
And get more of the latest health data and insights in your inbox each week with our dedicated newsletter: